Azoospermia due to aperistalsis of the vas deferens: Successful treatment with pseudoephedrine

Urology

Volumn 53, Issue 2, 1999, Pages 417-419

  Tillem, Steven M ^a   Mellinger, Brett C ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PSEUDOEPHEDRINE;

ADRENERGIC NERVE; ADULT; ARTICLE; AZOOSPERMIA; CASE REPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALE INFERTILITY; PERISTALSIS; PRIORITY JOURNAL; SEMEN ANALYSIS; SEMINAL VESICLE; SPERMATOGENESIS; SPERMATOZOON DENSITY; TESTIS BIOPSY; VAS DEFERENS;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; EPHEDRINE; HUMANS; MALE; OLIGOSPERMIA; VAS DEFERENS;

EID: 0032919942     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00339-2     Document Type: Article

References (15)

1. McLeod D.G., Reynolds D.G., Demaree G.E. Some pharmacologic characteristics of the human vas deferens. Invest Urol. 10:1973;338-341.
2. Bruschini H., Schmidt R.A., Tanagho E.A. Studies on the neurophysiology of the vas deferens. Invest Urol. 15:1977;112-116.
3. Anton P.G., McGrath J.C. Further evidence for adrenergic transmission in the human vas deferens. J Physiol. 273:1977;45-55.
4. Murphy J.B., Lipshultz L.I. Abnormalities of ejaculation. Urol Clin North Am. 14:1987;583-596.
5. Proctor K.G., Howards S.S. The effect of sympathomimetic drugs on post-lymphadenectomy azoospermia. J Urol. 129:1983;837-838.
6. Singh H. A case of inhibition of ejaculation as a side effect of Mellaril. Am J Psychiatry. 117:1961;1041-1042.
7. Freyhan F.A. Loss of ejaculation during Mellaril treatment. Am J Psychiatry. 118:1961;171-172.
8. Heller J. Another case of inhibition of ejaculation as a side effect of Mellaril. Am J Psychiatry. 118:1961;173.
9. Kedia K., Markland C. The effect of pharmacologic agents on ejaculation. J Urol. 114:1975;569-572.
10. Tiffany P., Goldstein M. Aperistalis of the vas deferens corrected with administration of ephedrine. J Urol. 133:1985;1060-1061.
11. Partin A.W., Coffey D.S. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. Walsh P.C., Retik A.B., Vaughan E.D., et al. 7th ed. Campbell's Urology. vol 2:1998;1381-1428 WB Saunders, Philadelphia.
12. Hollister L.E. Antipsychotic agents and lithium. Katzung B.G. Basic and Clinical Pharmacology. 1989;345-358 Appleton & Lange, East Norwalk, Connecticut.
13. Physicians' Desk Reference. Montvale, New Jersey, Medical Economics Company, 1997, pp 1348-1352.
14. Physicians' Desk Reference. Montvale, New Jersey, Medical Economics Company, 1997, pp 1993-1996.
15. Sneddon P., Westfall D.P. Pharmacologic evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol. 347:1984;561-580.